Clinical trial
Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
NCT00439543 · Interstitial Lung Disease Study Group, Korea, Other · Unknown status
Key facts
| NCT number | NCT00439543 |
|---|---|
| Title | Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis |
| Official title | Inhaled Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis |
| Lead sponsor | Interstitial Lung Disease Study Group, Korea, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Fibrosis, Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Iloprost inhalation |
| Enrollment | 15 |
| Start date | Mar 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Feb 23, 2007 |
| Last update posted | Feb 23, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: